A pivotal clinical phamacodynamic study of Zoreline one-month formulation
Latest Information Update: 15 Mar 2022
Price :
$35 *
At a glance
- Drugs Goserelin (Primary)
- Indications Breast cancer; Endometriosis; Prostate cancer
- Focus Pharmacodynamics; Registrational
- Sponsors Mithra Pharmaceuticals
- 08 Mar 2022 According to a Mithra Pharmaceuticals media release, the company expect to launch this trial at the end of 2022 or begin of 2023.
- 01 Mar 2019 According to a Mithra Pharmaceuticals media release, the study is plannned to be initiated in second half of 2019. Based on results of this study the company plans to file for marketing authorization via patners.
- 09 Jan 2019 New trial record